ATE318596T1 - Succinimid- und maleimidderivate und ihre verwendung als katalytische inhibitoren der topoisomerase ii - Google Patents
Succinimid- und maleimidderivate und ihre verwendung als katalytische inhibitoren der topoisomerase iiInfo
- Publication number
- ATE318596T1 ATE318596T1 AT02718005T AT02718005T ATE318596T1 AT E318596 T1 ATE318596 T1 AT E318596T1 AT 02718005 T AT02718005 T AT 02718005T AT 02718005 T AT02718005 T AT 02718005T AT E318596 T1 ATE318596 T1 AT E318596T1
- Authority
- AT
- Austria
- Prior art keywords
- topoisomerase
- succinimide
- maleimide
- formula
- maleimide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200100522 | 2001-03-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE318596T1 true ATE318596T1 (de) | 2006-03-15 |
Family
ID=8160403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02718005T ATE318596T1 (de) | 2001-03-29 | 2002-03-27 | Succinimid- und maleimidderivate und ihre verwendung als katalytische inhibitoren der topoisomerase ii |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1373494B1 (de) |
AT (1) | ATE318596T1 (de) |
AU (1) | AU2002249103A1 (de) |
DE (1) | DE60209471D1 (de) |
WO (1) | WO2002078679A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7291693B2 (en) | 2001-06-25 | 2007-11-06 | Massachusetts Institute Of Technology | Bioerodible conducting materials |
US7659278B2 (en) | 2002-02-21 | 2010-02-09 | Aprea Ab | Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases |
GB0303319D0 (en) | 2003-02-13 | 2003-03-19 | Novartis Ag | Organic compounds |
WO2005004861A1 (en) * | 2003-07-15 | 2005-01-20 | Korea Research Institute Of Bioscience And Biotechnology | A use of novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same |
US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
US7687508B2 (en) | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
US7629351B2 (en) | 2006-07-28 | 2009-12-08 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process |
US7671062B2 (en) | 2006-07-28 | 2010-03-02 | Bristol-Myers Squibb Company | Modulators of chemokine receptor activity, crystalline forms and process |
US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9123396D0 (en) * | 1991-11-04 | 1991-12-18 | Hoffmann La Roche | A process for the manufacture of substituted maleimides |
GB9605533D0 (en) * | 1996-03-15 | 1996-05-15 | Unilever Plc | Modified aluminosilicate |
DE19838506C2 (de) * | 1998-05-04 | 2000-08-31 | Asta Medica Ag | Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen |
JP2002527419A (ja) * | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Gsk−3阻害物質としてのピロール−2,5−ジオン類 |
JP4422916B2 (ja) * | 1999-03-12 | 2010-03-03 | トポターゲット・アクティーゼルスカブ | アントラサイクリン類の事故的溢血の処置 |
JP5409981B2 (ja) * | 2000-05-15 | 2014-02-05 | セルジーン コーポレイション | 癌治療用の組成物および方法 |
-
2002
- 2002-03-27 DE DE60209471T patent/DE60209471D1/de not_active Expired - Fee Related
- 2002-03-27 WO PCT/DK2002/000213 patent/WO2002078679A2/en not_active Application Discontinuation
- 2002-03-27 AU AU2002249103A patent/AU2002249103A1/en not_active Abandoned
- 2002-03-27 AT AT02718005T patent/ATE318596T1/de not_active IP Right Cessation
- 2002-03-27 EP EP02718005A patent/EP1373494B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1373494A2 (de) | 2004-01-02 |
WO2002078679A2 (en) | 2002-10-10 |
WO2002078679A3 (en) | 2002-12-19 |
AU2002249103A1 (en) | 2002-10-15 |
EP1373494B1 (de) | 2006-03-01 |
DE60209471D1 (de) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400480A1 (ru) | N-замещённые производные пирролидина в качестве ингибиторов дипептидилпептидазы | |
DE60026155D1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
NO20080150L (no) | Inhibitorer av AKT-aktivitet | |
BR0114023A (pt) | Derivados de imidazol como inibidores de quinase raf | |
BRPI0515500A (pt) | derivados piridazina para inibição de estearoil-coa-desaturase | |
ATE370139T1 (de) | Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs | |
TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
TR200102020T2 (tr) | Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler. | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
ATE556048T1 (de) | Prolinderivate und ihre verwendung als heilmittel | |
NO20025601D0 (no) | Arylmetylaminderivater for anvendelse som tryptaseinhibitorer | |
ATE537830T1 (de) | Nicotinamid derivate und ihre verwendung als therapeutika | |
DE69922216D1 (de) | Porphyrin derivate, ihre verwendung in der photodynamischen therapie und diese enthaltende medizinische geräte | |
NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
HUP0300169A2 (en) | Pyrrolidines which inhibit camp-specific pde, pharmaceutical compositions containing them and their use | |
BRPI0418099A (pt) | compostos, composição farmacêutica, e uso de um composto | |
DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
ATE302203T1 (de) | Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen | |
ATE318596T1 (de) | Succinimid- und maleimidderivate und ihre verwendung als katalytische inhibitoren der topoisomerase ii | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
BR0311491A (pt) | Composto, composição farmacêutica, uso de um composto, e, método terapêutico para tratar câncer em um mamìfero | |
EA200601687A1 (ru) | Тетрагидроизохинолиновые и тетрагидробензазепиновые производные (варианты), фармацевтическая композиция и фармацевтический набор, лекарственное и эталонное средство для тест-систем на их основе, способ лечения и профилактики заболевания, при котором благоприятна понижающая регуляция или ингибирование экспрессии или функции рецептора igf-1 | |
ATE424200T1 (de) | Solubilisierte topoisomerase-gift-mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |